Request Expert

Expert. Expert is clinically trained as an Endocrinologist, and performs research in human physiology and clinical trials. The basis of
his work is in moving discoveries from the concept stage into human testing, often undertaking first-in-human studies or early
stage clinical trials. His focus is on the persistingly increased morbidity and mortality from heart disease associated with diabetes
and obesity. He has expertise in detailed in vivo measurements of metabolic physiology and vascular function in human diabetes
and obesity, evaluating the metabolic and vascular consequences of dysregulated fuel metabolism. He is currently involved in
studies using Glucagon-like Peptide 1 (GLP-1) as a modulator of myocardial fuel metabolism, exploring applications of this
therapeutic class as protective factors in the setting of ischemia and other metabolic stresses. He is also involved in multicenter
federally-sponsored studies using antidiabetic agents in pre-diabetic populations, attempting to forestall the progression to
diabetes by restoring beta cell function.

Expert. Expert has provided consulting services to leading American and multinational pharmaceutical companies, helping assess products in development as candidate metabolic therapies and providing input on strategic choices in clinical trial programs in diabetes. He has also provided market consulting services on ad-hoc basis through investment brokerages.